We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YALA
651
Yalla Group
YALA
$824M
| $106K | 0.05% |
+15,296
| New | +$109K |
|
652
Nordic American Tanker
NAT
$1.35B
| $106K | 0.05% |
+30,708
| New | +$109K |
|
653
American Express Global Business Travel
GBTG
$4.92B
| $103K | 0.05% |
13,495
+2,796
| +26% | +$21.7K |
|
654
Turkcell
TKC
$4.78B
| $101K | 0.05% |
+18,484
| New | +$108K |
|
655
Gerdau
GGB
$9.72B
| $101K | 0.05% |
27,308
+5,240
| +24% | +$18.3K |
|
656
BlackBerry
BB
$4.74B
| $100K | 0.05% |
+26,445
| New | +$116K |
|
657
Orion Group Holdings
ORN
$485M
| $99.9K | 0.05% |
10,048
-11,693
| -54% | -$113K |
|
658
Teekay
TK
$981M
| $96.2K | 0.05% |
10,651
-1,184
| -10% | -$10.9K |
|
659
Aspen Aerogels
ASPN
$364M
| $95.7K | 0.05% |
+33,808
| New | +$174K |
|
|
NMAX
660
Newsmax Inc
NMAX
$1.03B
| $95.1K | 0.05% |
+12,307
| New | +$118K |
|
661
TMC The Metals Company
TMC
$1.56B
| $82.4K | 0.04% |
13,362
-2,666
| -17% | -$18.7K |
|
662
MBIA
MBI
$278M
| $81.4K | 0.04% |
11,375
-17,337
| -60% | -$125K |
|
663
ReNew
RNW
$2.22B
| $71.2K | 0.04% |
12,600
-13,702
| -52% | -$99.1K |
|
664
Thryv Holdings
THRY
$184M
| $68K | 0.03% |
11,241
-19,778
| -64% | -$157K |
|
|
CD
665
Chaince Digital Holdings
CD
$244M
| $66.1K | 0.03% |
+13,304
| New | +$154K |
|
|
YSG
666
Yatsen Holding
YSG
$322M
| $57.8K | 0.03% |
+14,848
| New | +$94.4K |
|
667
Bumble
BMBL
$393M
| $53.1K | 0.03% |
14,880
-59,161
| -80% | -$262K |
|
|
ABX
668
Abacus Global Management
ABX
$1.02B
| – | – |
-26,083
| Closed | -$149K |
|
669
Airbnb
ABNB
$90.9B
| – | – |
-3,681
| Closed | -$447K |
|
670
Arcosa
ACA
$7.13B
| – | – |
-2,331
| Closed | -$218K |
|
671
Archer Aviation
ACHR
$3.68B
| – | – |
-45,268
| Closed | -$434K |
|
672
ACV Auctions
ACVA
$1.43B
| – | – |
-13,967
| Closed | -$138K |
|
673
Adobe
ADBE
$99B
| – | – |
-622
| Closed | -$219K |
|
674
Analog Devices
ADI
$178B
| – | – |
-863
| Closed | -$212K |
|
675
Adient
ADNT
$1.7B
| – | – |
-14,556
| Closed | -$351K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.